Significant Funding Boosts Gastrointestinal Healthcare Innovation Market Growth

Gastrointestinal catheters market is anticipated to reach $5.5 billion in 2035 from $3.4 billion in 2024, growing at a CAGR of 4.5% during the forecast period (2025-2035). Gastrointestinal catheters are advanced medical devices used for the diagnosis and treatment of disorders of the digestive system, drainage of fluids, delivery of drugs, feeding, and disease diagnosis. GI catheters are additionally useful for the diagnosis of gastrointestinal disorders, pressure measurement, acid reflux testing, and contrast studies. It additionally assists in emergency procedures and therapy applications such as enteral nutrition tubes, bowel decompression, medication delivery, and hemostasis. 

Browse the full report description of “Gastrointestinal Catheters Market Size, Share & Trends Analysis Report by Product Type (Nasogastric Tubes, Percutaneous Endoscopic Gastrostomy (PEG) Tube, Gastrostomy Tubes (G-Tubes), Jejunostomy Tubes (J-Tubes), Gastrojejunostomy Tubes (GJ-Tubes), Rectal Catheters, Ileus Tube, and Others), and by Application (Enteral Feeding, Decompression and Drainage, Diagnostics and Therapeutic ), and by End-User (Hospitals & Clinics, Ambulatory Surgical Centers (ASCs), Long-Term Care Facilities, and Home Care Settings) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/gastrointestinal-catheters-market

The gastrointestinal healthcare market has seen significant investment in the development of emerging diagnostic and treatment technologies. The investment in Geneoscopy, Gemelli Biotech Corp., and Oshi Health is indicative of a desire to develop gastrointestinal diagnostics and treatments to improve patient outcomes and meet growing demand for effective healthcare technology. For instance, in January 2025, Geneoscopy raised $105 million in a Series C investment round led by Bio-Rad Laboratories. The investment is for the launch and commercialization of at-home stool-based colorectal cancer screen, ColoSense, in addition to further investment in its new diagnostic tests for inflammatory bowel disease. The investment will deploy ColoSense to healthcare providers in general.

Recent Development

• In October 2024, Oshi Health raised $60 million in Series C funding, led by Oak HC/FT, with contributions from current investors. The firm seeks to solidify its position as the category leader for virtual digestive care, as gastrointestinal care is a prevalent need, generating $136 billion in yearly costs.

• In April 2023, Oshi Health raised $30 million in Series B funding that was led by Koch Disruptive Technologies. The investment helps to fund Oshi Health's market growth and leadership, evidenced in its study results of symptom improvement and patient satisfaction. The firm is accessible to more than 20 million individuals as a preferred in-network virtual gastroenterology clinic for national and regional payers and employer clients. Oshi Health collaborates with GI community practices to expand access to care, including reimbursed access to evidence-based dietary and behavioral therapies to enhance GI outcomes.

• In June 2022, Gemelli Biotech Corp. raised $19 million Series A from Blue Ox Healthcare Partners and Cedars-Sinai. The funds will be utilized to expedite the commercialization of its trio-smart and IBS-smart precision diagnostic tests that quantify hydrogen, methane, and hydrogen sulfide levels to offer an all-around view of gut health. The tests were developed in collaboration with Cedars-Sinai's Medically Associated Science and Technology program.

Market Coverage

• The market numbers available for 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Type

o By Application

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Abbott Laboratories, B. Braun SE, Boston Scientific Corp., Medtronic Inc., and Olympus Corp., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Gastrointestinal Catheters Market Report Segment

By Product Type

• Nasogastric Tubes
• Percutaneous Endoscopic Gastrostomy (PEG) Tube 
• Gastrostomy Tubes (G-Tubes)
• Jejunostomy Tubes (J-Tubes)
• Gastrojejunostomy Tubes (GJ-Tubes)
• Rectal Catheters
• Ileus Tube
• Others (Biliary Drainage Catheter, ERCP Catheter, Percutaneous Endoscopic Jejunostomy (PEJ) Tube, and Other)

By Application

• Enteral Feeding
• Decompression and Drainage
• Diagnostics 
• Therapeutic 

By End-User

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)
• Long-Term Care Facilities
• Home Care Settings

Global Gastrointestinal Catheters Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/gastrointestinal-catheters-market